Note: Ingredients listed on restricted chemical lists
EC/CAS
200-559-2/63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
EC/CAS
209-150-3/557-04-0
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
EC/CAS
232-940-4/9050-36-6
Name of the chemical
Maltodextrin
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
N/A
General Information
Revision date
2019-02-14
Product name
GENERESS FE TABLETSNorethindrone/Ethinyl Estradiol Tablets 0.8 mg/25 mcg and Ferrous Fumarate Tablets
Product Synonyms
NDC 0023-6030 -03
Chemical name
17-Hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one/19-Nor-17α-pregna-1,3,5 (10)-trien-20-yne-3,17-diol
supplier name
U.S
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
U.S
GHS Information
Signal word
Not Applicable
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Not Applicable Not Applicable
Signal word
Not Applicable
Hazard statements
Not Applicable EU LABELING AND CLASSIFICATION 67/548/EEC: According to Article 1 of European Union Council Directive 92/32/EEC, medical products in the finished state for human use (as defined by European Union Council Directives 67/548/EEC and 87/21/EEC) are not subject to the regulations and administrative provisions of European Union Council Directive 92/32/EEC. Not Applicable
Precautionary statements
Not Applicable See Section 16 for full EU classification information of product and components and full text of hazard and precautionary statements. EMERGENCY OVERVIEW
Product definition
This product is supplied as 24 light green, round tablets (active) each containing 0.8 mg norethindrone and 0.025 mg ethinyl estradiol. 4 brown, round tablets (non-hormonal placebo) each containing 75 mg ferrous fumarate.
Health hazards
The chief health hazard associated with overexposures during normal use and handling is the potential for irritation of contaminated skin. Estrogen-progestogen oral contraceptives (such as this product) are known human carcinogens. Norethindrone combined with Ethinyl Estradiol (the active components in this product) is a reproductive toxin. Individuals who have had allergic reactions to prescription as well as to over- the-counter products containing estrogens and/or progestogens may experience allergic reactions to this product. Therapeutic use of this product can cause adverse symptoms of the cardiac system, pulmonary system, gallbladder, gastrointestinal system, and liver. Flammability Hazards: If heated to high temperatures for a prolonged period, the product may ignite. When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds (including carbon monoxide and carbon dioxide). Reactivity Hazards: This product is not reactive.
Environmental hazards
Large quantities released to the aquatic and terrestrial environment may have an adverse effect. Emergency Considerations: Emergency responders should wear appropriate protection for situation to which they respond.